Therefore, Inosine enhances the efficacy of ICB therapy and is also considered a potential immune adjuvant.[52] The use of synthetically developed Escherichia coli strains that produce large amounts of L‐arginine to colonize tumors, enhances anti‐cancer efficacy of anti‐PD‐L1 antibodies. This evidence concerns the gene CD274 and cancer.